ACURATE neo2 valve versus commercially available transcatheter heart valves in patients with severe aortic stenosis (ACURATE IDE): a multicentre, randomised, controlled, non-inferiority trial

Authors: Rassi, Andrew N | Lancet (London, England) | May 20, 2025 | PubMed abstract

Explore all publications

Back To Top